Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe cost of 7.5 mg Mounjaro in the UK's private market typically falls somewhere in the range of roughly £149 to £375 per four-week pen, depending on the provider and what's bundled in — a range that widened significantly after Eli Lilly raised its UK list price from 1 September 2025, with the highest doses moving from around £122 to around £330 at list level. Mounjaro is a prescription-only medicine: no pharmacy, regulated or otherwise, can hand it over without a prescriber first deciding it's clinically appropriate for you. At 7.5 mg you're already a few steps into the titration schedule, which means a legitimate provider should be checking your progress, not just posting the next pen. What you pay for matters at least as much as the number itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro's licensed titration schedule starts at 2.5 mg, and each step up serves a clinical purpose. The SURMOUNT-1 trial, published in the New England Journal of Medicine, enrolled adults at obesity levels and tested doses up to 15 mg over 72 weeks; those reaching the highest tolerated dose achieved average body-weight reductions of around 20–21%. The 7.5 mg dose is the mid-tier of the schedule, past the tolerability phase, into the range where the medicine begins to do its primary job. That context matters for pricing, because reaching 7.5 mg means you've already had at least two dose reviews. A provider who doesn't verify your progress before sending the next pen is cutting corners that have clinical consequences, not just commercial ones.
NICE's recommendation for tirzepatide (TA1026) makes clear that treatment should continue only where meaningful weight loss is being achieved. That's not bureaucracy, it's the framework that protects you. Any cost calculation for 7.5 mg Mounjaro should sit inside that clinical conversation, not outside it.
A price listed online for a Mounjaro pen is frequently just that: the pen. Consultation fees are sometimes charged separately, anything from £25 to £80 depending on the clinic. Prescription fees can appear as a discrete line item. Delivery is often added at checkout, particularly for tracked or refrigerated dispatch. Follow-up reviews, dose-increase assessments and aftercare calls are charged by some providers per appointment, which adds up quickly if you're titrating through several doses over several months.
The full picture of what Mounjaro costs privately becomes clearer once those extras are added back in. A pen priced at £149 with a £40 consultation fee, a £15 prescription charge and a £7 delivery surcharge is a different proposition from a single all-inclusive figure. Worth doing the arithmetic before comparing providers purely on the pen price shown in a search result. One practical thing to note: Mounjaro pens need refrigerating at 2–8°C, so if a provider's dispatch and packaging don't account for cold-chain integrity, a cheaper pen isn't the bargain it looks like sitting in your fridge door.
nume is deliberately not positioned as the cheapest option in the market. What the single transparent price covers: the consultation, the prescriber's review, the prescription, the medicine itself, tracked next-working-day DPD delivery and ongoing aftercare, every repeat order reviewed clinically before it goes out. No subscription. No auto-renewal. No hidden extras at checkout. Current pricing is shown on the treatment page rather than in body copy, because treatment prices can change and we'd rather you see the live figure than a number printed weeks ago.
If you want to compare the 7.5 mg cost more specifically, the dedicated 7.5 mg price page sets out the context in more detail, and what 5 mg costs gives a useful comparison point for the previous step. Our prescribers are also the right people to ask about whether 7.5 mg is the dose your situation calls for, that's a clinical question, not a product selection.
The MHRA has warned publicly about counterfeit weight-loss pens sold without clinical assessment, including fake tirzepatide pens seized from an illicit UK manufacturing site in late 2025. The safe route is through a pharmacy you can verify on the GPhC register, nume's premises registration number is 9012878. Red flags include sellers offering Mounjaro without a prescription, prices sitting well below the private market range, or discount codes and coupons from sources you can't trace back to a regulated pharmacy. For a prescription medicine at the 7.5 mg stage, the cheapest listing answers the wrong question. The right question is whether the provider has a real prescriber reading your notes, a licensed supply chain and a clinical process that doesn't stop at the first sale.
You can check eligibility and start a free consultation through the weight-loss treatments page. If you'd like to read more about how Mounjaro works across the full dose range, the Mounjaro overview covers the clinical picture in one place. Questions about pricing in general, including where to find cheap Mounjaro 7.5 mg from a regulated source, sit on the Mounjaro price page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.